Legal & General Group PLC Mersana Therapeutics, Inc. Transaction History

Legal & General Group PLC

$470 Billion
Q3 2024

A detailed history of Legal & General Group PLC transactions in Mersana Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 11,097 shares of MRSN stock, worth $24,524. This represents 0.0% of its overall portfolio holdings.

Number of Shares

11,097

Previous 11,097 -0.0%

Holding current value

$24,524

Previous $20,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$2.16 - $5.94 $39,808 - $109,474	-18,430 Reduced 62.42%	11,097 $49,000
Q4 2023 Feb 15, 2024	SELL	$1.11 - $2.34 $26,234 - $55,305	-23,635 Reduced 44.46%	29,527 $68,000
Q3 2023 Nov 14, 2023	SELL	$1.06 - $3.91 $20,855 - $76,929	-19,675 Reduced 27.01%	53,162 $67,000
Q2 2023 Aug 14, 2023	BUY	$3.08 - $9.55 $112,071 - $347,495	36,387 Added 99.83%	72,837 $239,000
Q1 2023 May 15, 2023	BUY	$4.0 - $7.02 $5,044 - $8,852	1,261 Added 3.58%	36,450 $149,000
Q4 2022 Feb 14, 2023	BUY	$5.65 - $7.86 $7,356 - $10,233	1,302 Added 3.84%	35,189 $206,000
Q3 2022 Nov 14, 2022	BUY	$4.63 - $8.0 $10,838 - $18,728	2,341 Added 7.42%	33,887 $229,000
Q2 2022 Aug 22, 2022	BUY	$2.84 - $5.0 $17,752 - $31,255	6,251 Added 24.71%	31,546 $145,000
Q1 2022 May 16, 2022	BUY	$3.74 - $6.63 $676 - $1,200	181 Added 0.72%	25,295 $101,000
Q3 2021 Nov 15, 2021	BUY	$8.56 - $14.47 $95,084 - $160,732	11,108 Added 79.31%	25,114 $236,000
Q2 2021 Aug 12, 2021	BUY	$13.28 - $18.07 $12,071 - $16,425	909 Added 6.94%	14,006 $190,000
Q1 2021 May 17, 2021	SELL	$15.31 - $26.52 $7,777 - $13,472	-508 Reduced 3.73%	13,097 $212,000
Q4 2020 Feb 12, 2021	SELL	$16.84 - $27.59 $1,633 - $2,676	-97 Reduced 0.71%	13,605 $362,000
Q3 2020 Nov 13, 2020	SELL	$16.2 - $25.7 $18,079 - $28,681	-1,116 Reduced 7.53%	13,702 $255,000
Q2 2020 Aug 14, 2020	BUY	$5.24 - $23.4 $52,887 - $236,176	10,093 Added 213.61%	14,818 $347,000
Q1 2020 May 14, 2020	SELL	$4.41 - $9.28 $5,600 - $11,785	-1,270 Reduced 21.18%	4,725 $27,000
Q2 2019 Aug 14, 2019	BUY	$3.84 - $6.4 $15,598 - $25,996	4,062 Added 210.14%	5,995 $24,000
Q2 2018 Aug 10, 2018	SELL	$14.2 - $22.68 $312 - $498	-22 Reduced 1.13%	1,933 $35,000
Q1 2018 May 17, 2018	BUY	$13.56 - $18.48 $16,977 - $23,136	1,252 Added 178.09%	1,955 $31,000
Q4 2017 Feb 13, 2018	BUY	$14.95 - $19.9 $10,509 - $13,989	703	703 $12,000

Others Institutions Holding MRSN

# of Institutions

121

Shares Held

116M

Call Options Held

233K

Put Options Held

457K

View Full List

About Mersana Therapeutics, Inc.

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $215M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

More about MRSN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Mersana Therapeutics, Inc. Transaction History